A Kiwi nanotech company has cut the ribbon at its new US headquarters, located in the growing science and tech hub of Massachusetts.
Izon Science, which has developed the world's first nanopore based measurement system available for general use, said its Cambridge facility would enable it to better support its expanding client base in 23 countries.
"We've located ourselves amongst a thriving life sciences community, which is also the premier academic community in the world," said executive chairman Hans van der Voorn.
"Being located in Cambridge allows us to share research ideas, build relationships, and develop new opportunities and products, both within Massachusetts and the rest of the US."
Dr Susan Windham-Bannister, president and chief executive of the Massachusetts Life Sciences Center, said the state was a centre for innovation in science and technology.
"Izon's decision to locate here attests to the strength of our life sciences workforce and the opportunities to partner with leading companies and academic institutions."
According to Robert Coughlin, president and chief executive of MassBio, Massachusetts is a good place for international life science companies to do business.
"Izon is yet another example of the strength of the Massachusetts cluster to bring together partners from around the world and across the life sciences spectrum to collaborate on the next generation of treatments and cures.
"We are pleased to welcome Izon as they continue their growth and expansion as a leading nanotechnology instrument manufacturer."
Izon's instruments are used for measurement, control, and analysis of particles across a wide range of scientific fields including bionanotechnology, vaccinology, microbiology, and environmental science. As well as head offices in Christchurch and the US, it has its European headquarters in Oxford in the UK.